V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007952 | 290005412 | null | null | Palliative (P) | 2016-07-12 | 2016-07-13 | CARBOPLATIN + PACLITAXEL | null | Y | 290022052 | PEMBROLIZUMAB |
| 290007955 | 290005419 | 0 | 45 | Disease modification (D) | 2014-10-12 | 2014-11-16 | Capecitabine | N | N | 290022087 | RITUXIMAB |
| 290007956 | 290005420 | null | 48.5 | Curative (C) | 2017-11-29 | 2018-01-26 | CETUXIMAB + IRINOTECAN + MDG | N | Y | 290022089 | CISPLATIN + VINORELBINE + RT |
| 290007957 | 290007299 | 1.65 | 76.3 | Palliative (P) | 2018-09-29 | 2018-11-18 | LANREOTIDE | N | N | 290022112 | CAPECITABINE + CISPLATIN |
| 290007958 | 290005425 | 1.73 | 59.8 | Palliative (P) | 2018-02-06 | 2018-03-05 | Capecitabine + Oxaliplatin 21day | N | null | 290022118 | TRASTUZUMAB + VINORELBINE |
| 290007959 | 290005429 | 1.6 | 65 | Palliative (P) | 2018-01-12 | 2018-01-17 | Capecitabine | 02 | N | 290022147 | CAPECITABINE + IRINOTECAN |
| 290007960 | 290008419 | 1.72 | 51.6 | Disease modification (D) | 2017-02-27 | 2017-03-27 | Capecitabine + Mitomycin | 2 | N | 290022185 | RITUXIMAB |
| 290007961 | 290005432 | 1.81 | null | null | 2018-06-28 | 2018-07-20 | Cetuximab 14 day | N | N | 290022192 | CISPLATIN + FLUOROURACIL + RT |
| 290007962 | 290005435 | 1.61 | 60.8 | Curative (C) | 2018-01-02 | 2018-01-18 | CISPLATIN + RT | 02 | null | 290022214 | CHOP R |
| 290007963 | 290005442 | 1.9 | null | Palliative (P) | 2016-09-28 | 2016-09-30 | CETUXIMAB | N | N | 290022243 | PACLITAXEL |
| 290007964 | 290005446 | 1.6 | 73.2 | Palliative (P) | 2017-10-07 | 2017-10-15 | Cisplatin + Radiotherapy | N | N | 290022257 | TRASTUZUMAB + VINORELBINE |
| 290007965 | 290005448 | null | 44.4 | Adjuvant (A) | 2016-11-18 | 2016-11-22 | BALLAD Trial | 02 | N | 290022260 | CAPECITABINE + OXALIPLATIN |
| 290007966 | 290005450 | 1.78 | 50 | null | null | 2016-12-05 | EVEROLIMUS | N | null | 290022270 | LANREOTIDE |
| 290007967 | 290005451 | 1.71 | 144.7 | Curative (C) | 2017-11-26 | 2017-11-27 | CAPECITABINE + IRINOTECAN | 02 | N | 290022278 | CISPLATIN + RT |
| 290007968 | 290005455 | 1.52 | 48.2 | Curative (C) | 2018-10-23 | 2018-10-23 | Carboplatin AUC 6 - 10 | 02 | Y | 290022286 | CISPLATIN + RT |
| 290007969 | 290005457 | 1.62 | 60.2 | Disease modification (D) | 2017-03-10 | 2017-04-26 | Capecitabine 35days + RT | N | N | 290022294 | LANREOTIDE |
| 290007970 | 290005460 | 1.7 | 86 | Palliative (P) | 2017-12-23 | 2018-01-12 | Fluorouracil PVI + Mitomycin 42 day | N | N | 290022307 | PACLITAXEL |
| 290007971 | 290005461 | 1.52 | 82.9 | Palliative (P) | 2016-05-17 | 2016-05-20 | LANREOTIDE | 02 | N | 290022310 | MCX |
| 290007972 | 290005462 | 0 | null | Curative (C) | 2016-01-13 | 2017-11-15 | PERTUZUMAB + TRASTUZUMAB | 02 | N | 290022311 | MITOMYCIN |
| 290007973 | 290005466 | 1.58 | 53 | Palliative (P) | 2018-11-29 | 2018-12-01 | Cisplatin | 02 | N | 290022326 | CAPECITABINE |
| 290007974 | 290005470 | 1.58 | 53.2 | Palliative (P) | 2016-01-14 | 2016-03-06 | CARBOPLATIN + ETOPOSIDE | N | null | 290022373 | CETUXIMAB + CISPLATIN + FU |
| 290007975 | 290005473 | 1.72 | 61.9 | Palliative (P) | 2013-06-30 | 2015-02-09 | NIVOLUMAB | 02 | N | 290022389 | CAPECITABINE + MITOMYCIN |
| 290007976 | 290005475 | 1.78 | 71.4 | Curative (C) | 2014-01-09 | 2014-01-29 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 290022390 | CISPLATIN + RT |
| 290007977 | 290005476 | 1.72 | null | Palliative (P) | 2018-02-09 | 2018-03-08 | CARBOPLATIN + ETOPOSIDE | N | N | 290022398 | PACLITAXEL |
| 290007978 | 290005479 | null | 52 | Curative (C) | 2016-11-25 | 2016-11-28 | MITOMYCIN | N | N | 290022406 | CAPECITABINE + OXALIPLATIN |
| 290007979 | 290005481 | 1.73 | 70.7 | Palliative (P) | 2015-04-08 | 2015-04-21 | LANREOTIDE | 02 | N | 290022408 | CETUXIMAB + CISPLATIN + FU |
| 290007980 | 290005486 | 1.79 | 93 | Curative (C) | 2017-04-27 | 2017-07-20 | FEC 100 | 02 | N | 290022420 | CISPLATIN + RT |
| 290007981 | 290005491 | 1.78 | 84.3 | Palliative (P) | 2017-07-08 | 2017-09-21 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 290022433 | GEMCITABINE |
| 290007982 | 290005495 | null | 80 | Palliative (P) | null | 2018-09-06 | Irinotecan | N | N | 290022438 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 290007984 | 290005500 | null | 93 | null | 2017-08-30 | 2017-09-08 | CAPECITABINE + RT | N | N | 290022478 | CAPECITABINE + OXALIPLATIN |
| 290007985 | 290007328 | 1.64 | 0 | Palliative (P) | 2014-01-06 | 2014-02-01 | LANREOTIDE | 02 | N | 290022484 | IRINOTECAN |
| 290007986 | 290005501 | null | 55.6 | Palliative (P) | 2017-04-11 | 2018-01-02 | CAPECITABINE + OXALIPLATIN | N | N | 290022486 | LANREOTIDE |
| 290007987 | 290005502 | null | null | Adjuvant (A) | 2016-06-11 | 2016-06-14 | CARBOPLATIN + PACLITAXEL | N | null | 290022492 | CAPECITABINE |
| 290007988 | 290005503 | 1.58 | 67 | Curative (C) | 2015-06-12 | 2015-06-26 | LANREOTIDE | 01 | N | 290022501 | CAPECITABINE + RT |
| 290007989 | 290005509 | 1.6 | 0 | Palliative (P) | 2018-06-03 | 2018-06-28 | CAPECITABINE + MITOMYCIN + RT | N | N | 290022503 | CAPECITABINE + OXALIPLATIN |
| 290007990 | 290005511 | 1.57 | 67.6 | Palliative (P) | 2017-09-21 | 2017-10-05 | CARBOPLATIN + ETOPOSIDE | null | null | 290022514 | PANITUMUMAB |
| 290007991 | 290005512 | 1.5 | 75.9 | Palliative (P) | 2014-02-14 | 2014-03-22 | Capecitabine + Oxaliplatin 21day | N | N | 290022520 | CAPECITABINE |
| 290007992 | 290005515 | 1.69 | null | null | 2017-11-30 | 2017-12-16 | DHAP - R | null | null | 290022527 | LANREOTIDE |
| 290007993 | 290005520 | 1.73 | 54 | Adjuvant (A) | 2018-08-04 | 2018-09-23 | Docetaxel | N | N | 290022559 | CAPECITABINE |
| 290007994 | 290005522 | 1.6 | null | Neo-adjuvant (N) | null | 2018-03-16 | CARBOPLATIN + RT | 02 | N | 290022560 | CAPECITABINE + RT |
| 290007995 | 290007338 | 1.77 | 49.4 | Disease modification (D) | 2014-06-06 | 2014-06-06 | CARBOPLATIN + RT | N | N | 290022562 | OCTREOTIDE |
| 290007996 | 290005525 | 1.53 | 54.5 | Palliative (P) | 2015-04-27 | 2015-05-29 | LANREOTIDE | N | Y | 290022565 | LANREOTIDE |
| 290007997 | 290005528 | 1.71 | 89.55 | Palliative (P) | 2018-02-08 | 2018-10-29 | Y-90 | 2 | N | 290022569 | NIVOLUMAB |
| 290007998 | 290005531 | 1.78 | null | Curative (C) | 2018-02-21 | 2018-03-15 | R CODOX M | N | N | 290022602 | CARBOPLATIN + RT |
| 290007999 | 290007342 | 1.9 | 69.2 | Disease modification (D) | 2015-07-28 | 2015-09-12 | CAPECITABINE + CARBOPLATIN | N | N | 290022604 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290008000 | 290005535 | 1.7 | 72.8 | Palliative (P) | 2014-03-27 | 2014-07-17 | Sunitinib | N | N | 290022610 | MELPHALAN |
| 290008001 | 290007345 | 1.69 | 64 | Palliative (P) | 2015-09-04 | 2015-12-06 | Trial Unspecified | N | N | 290022612 | TRIAL |
| 290008002 | 290005537 | 1.76 | null | Palliative (P) | 2015-11-08 | 2015-12-17 | DOCETAXEL + GEMCITABINE | N | null | 290022619 | CETUXIMAB |
| 290008003 | 290005538 | null | null | Palliative (P) | 2015-08-05 | 2015-08-08 | Capecitabine + Oxaliplatin 21day | 02 | null | 290022620 | REGORAFENIB |
| 290008004 | 290005540 | 1.65 | 33 | Palliative (P) | 2018-01-12 | 2018-03-02 | PACLITAXEL + TRASTUZUMAB | null | Y | 290022645 | EVEROLIMUS |